SUBSCRIBE
SUBSCRIBE

Postmarket research

Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
GlaxoSmithKline, Theravance’s Breo Fails to Extend Lives in Ambitious Study
September 8, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Intarcia Diabetes Implant Beats Merck & Co.'s $6 Billion Drug in Head-to-Head Study
August 19, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG Reports Third Case of PML in Relapsing MS Patient Treated with Gilenya
August 18, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Drug Development
Pfizer Pulls Plug on OTC Lipitor After Trial Failure
July 29, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Heart-Stopping Morning Leads to Vertex Rise As FDA News Sees Positives
May 8, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Gilead Offers Free Drugs in Georgia in Hep C Eradication Experiment
April 23, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
AstraZeneca PLC’s Diabetes Drug Onglyza May Increase Risk of Heart Failure, FDA Panel Reports
April 10, 2015
 · 
2 min read
Drug Development
Roche Scientists Testing to See if Arthritis Blockbuster Will Work for Diabetes
April 10, 2015
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Deaths Review of Eli Lilly’s Antipsychotic Zyprexa Relprevv “Inconclusive”
March 24, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Gilead Warns After Nine Hepatitis Patients Taking Heart Drug Develop Condition, One Dies From Cardiac Arrest
March 23, 2015
 · 
2 min read
Load More
PRESS RELEASES
Drug Development
Eli Lilly Release: Jardiance (Empagliflozin) Tablets Reduced Risk Of Cardiovascular Death In People With Type 2 Diabetes And Established Cardiovascular Disease Independent Of Background Blood Sugar Control
September 12, 2017
 · 
13 min read
Drug Development
Galderma Pharma S.A.: Combined Use Of Rosacea Therapies Ivermectin 1% Cream And Brimonidine 0.33% Gel Evaluated In MOSAIC Study
September 11, 2017
 · 
2 min read
Drug Development
Eli Lilly Builds Upon Body Of Clinical Evidence For CYRAMZA (Ramucirumab) With Phase III RANGE Data Demonstrating Superior Progression-Free Survival In Advanced Or Metastatic Urothelial Cancer
September 11, 2017
 · 
22 min read
Drug Development
Boehringer Ingelheim Pharmaceuticals, Inc. Release: Results from The INJOURNEY Trial Investigating Ofev With Add-On Pirfenidone Provide New Insights Into This Combination Treatment For IPF
September 11, 2017
 · 
8 min read
Drug Development
American Association of Oral & Maxillofacial Surgeons Release: JOMS Study: Immunosuppressant Drugs Raise Risks For Oral Cancer Patients
September 11, 2017
 · 
2 min read
Drug Development
NYU Langone Health Release: Alternative Immunotherapy Drug More Effective Than Current Standard Of Care In Treating Advanced Melanoma After Surgical Removal Of Disease
September 11, 2017
 · 
4 min read
Drug Development
Eisai Inc. Release: Lenvatinib Delays Deterioration In Certain Domains Of Quality Of Life In Patients With Unresectable Hepatocellular Carcinoma As Compared To Sorafenib In Phase III REFLECT Study
September 11, 2017
 · 
15 min read
Drug Development
ImmusanT, Inc. Presents Data From Multiple Studies Supporting Continued Development Of Nexvax2
September 11, 2017
 · 
5 min read
Drug Development
Boehringer Ingelheim Release: Safety And Efficacy Results From The INJOURNEY Trial Investigating OFEV (Nintedanib) With Add-On Pirfenidone Provide New Data To Support Nintedanib’s Key Role In IPF
September 11, 2017
 · 
5 min read
Drug Development
Aequus Pharmaceuticals Announces Positive Results For Proof Of Concept Clinical Trial Of Anti-Nausea Patch
September 8, 2017
 · 
3 min read
Drug Development
Bexion Pharmaceuticals And CTI - Clinical Trial and Consulting Services Announce Completion Of First-In-Human Trial Using BXQ-350 For The Treatment Of Cancer
September 6, 2017
 · 
4 min read
Drug Development
EnteroMedics Begins Post-Approval Study For The Treatment Of Obesity With vBloc Therapy
September 6, 2017
 · 
6 min read
Drug Development
Recro Pharma Presents Phase III IV Meloxicam Clinical Safety And Opioid Use Data At Painweek 2017
September 5, 2017
 · 
11 min read
Drug Development
Eagle Pharma Announces Positive Results Of Study Conducted To Evaluate Neuroprotective Effects Of RYANODEX Secondary To Nerve Agent Exposure
September 5, 2017
 · 
6 min read
Drug Development
EMD Serono Release: Investigational Cladribine Tablets Demonstrates Sustained Disease Control Over 4 Years With Maximum Of 20 Days Oral Treatment
September 5, 2017
 · 
7 min read
Drug Development
Theraclion Reports Publication Of Promising Clinical Trial Results In A New Thyroid Indication
August 30, 2017
 · 
3 min read
Drug Development
BioNet-Asia Release: The HUG Completes The Pertado Trial Evaluating Pertagen, A New Recombinant Pertussis Vaccine, In Adolescents In Switzerland
August 29, 2017
 · 
3 min read
Drug Development
Bristol-Myers Squibb And Pfizer Present Observational Real-World Data Analysis On The Effectiveness And Safety Of Eliquis (Apixaban) Compared To Warfarin In Select High-Risk Patients With Non-Valvular Atrial Fibrillation
August 28, 2017
 · 
3 min read
Drug Development
Coherus Announces Positive Topline Results For Clinical Pharmacokinetic Bioequivalence Study For CHS-1420 (Humira® Biosimilar Candidate) Versus European Marketed Humira In Healthy Subjects
August 28, 2017
 · 
3 min read
Drug Development
Boehringer Ingelheim Release: Pradaxa (Dabigatran Etexilate) Dual Therapy Showed Lower Rates Of Major Bleeding Versus Triple Therapy With Warfarin In Atrial Fibrillation Patients Undergoing Stent Placement
August 28, 2017
 · 
4 min read
Load More